In Response

Akinori Maeda¹, Rinaldo Bellomo^{2

3

4}

Affiliations

¹ Department of Intensive Care, Austin Hospital, Melbourne, Australia.
² Department of Intensive Care, Austin Hospital, Melbourne, Australia, Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Australia.
³ Department of Critical Care, University of Melbourne, Melbourne, Australia.
⁴ Data Analytics Research and Evaluation Centre, Austin Hospital, Melbourne, Australia, rinaldo.bellomo@austin.org.au.

Akinori Maeda et al. Anesth Analg. 2024.

. 2024 Nov 1;139(5):e54-e55.

doi: 10.1213/ANE.0000000000007139. Epub 2024 Oct 21.

Akinori Maeda¹, Rinaldo Bellomo^{2

3

4}

¹ Department of Intensive Care, Austin Hospital, Melbourne, Australia.
² Department of Intensive Care, Austin Hospital, Melbourne, Australia, Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Australia.
³ Department of Critical Care, University of Melbourne, Melbourne, Australia.
⁴ Data Analytics Research and Evaluation Centre, Austin Hospital, Melbourne, Australia, rinaldo.bellomo@austin.org.au.

No abstract available

References

1. Wang S-H, Hee H-Z, Lu CW. Concerns and clarifications on the role of carboxyhemoglobin as a biomarker of hemolysis in cardiac surgery. Anesth Analg. 2024;139:e53–e54.
1. Maeda A, Pandey D, Inokuchi R, et al. Carboxyhemoglobin in cardiac surgery patients and its association with risk factors and biomarkers of hemolysis. Anesth Analg. 2024;139:789–797.
1. Feldman JM, Hendrickx J, Kennedy RR. Carbon dioxide absorption during inhalation anesthesia: a modern practice. Anesth Analg. 2021;132:993–1002.
1. Fang ZX, Eger EI 2nd, Laster MJ, Chortkoff BS, Kandel L, Ionescu P. Carbon monoxide production from degradation of desflurane, enflurane, isoflurane, halothane, and sevoflurane by soda lime and Baralyme. Anesth Analg. 1995;80:1187–1193.
1. Kennedy RR, Hendrickx JF, Feldman JM. There are no dragons: low-flow anaesthesia with sevoflurane is safe. Anaesth Intensive Care. 2019;47:223–225.